Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis
Top Cited Papers
- 1 May 2004
- Vol. 100 (S9) , 2026-2046
- https://doi.org/10.1002/cncr.20163
Abstract
BACKGROUND Oral and gastrointestinal (GI) mucositis can affect up to 100% of patients undergoing high‐dose chemotherapy and hematopoietic stem cell transplantation, 80% of patients with malignancies of the head and neck receiving radiotherapy, and a wide range of patients receiving chemotherapy. Alimentary track mucositis increases mortality and morbidity and contributes to rising health care costs. Consequently, the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology assembled an expert panel to evaluate the literature and to create evidence‐based guidelines for preventing, evaluating, and treating mucositis. METHODS Thirty‐six panelists reviewed literature published between January 1966 and May 2002. An initial meeting in January 2002 produced a preliminary draft of guidelines that was reviewed at a second meeting the same year. Thereafter, a writing committee produced a report on mucositis pathogenesis, epidemiology, and scoring (also included in this issue), as well as clinical practice guidelines. RESULTS Panelists created recommendations from higher levels of evidence and suggestions when evidence was of a lower level and there was a consensus regarding the interpretation of the evidence by the panel. Panelists identified gaps in evidence that made it impossible to recommend or not recommend use of specific agents. CONCLUSIONS Oral/GI mucositis is a common side effect of many anticancer therapies. Evidence‐based clinical practice guidelines are presented as a benchmark for clinicians to use for routine care of appropriate patients and as a springboard to challenge clinical investigators to conduct high‐quality trials geared toward areas in which data are either lacking or conflicting. Cancer 2004;100(9 Suppl):2026–2046. © 2004 American Cancer Society.Keywords
This publication has 161 references indexed in Scilit:
- Efficacy of Gelclair in Reducing Pain in Palliative Care Patients with Oral Lesions: Preliminary Findings from an Open Pilot StudyJournal of Pain and Symptom Management, 2002
- Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trialEuropean Journal Of Cancer, 2001
- Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancerEuropean Journal Of Cancer, 1999
- A randomized prospective study of endoscopic bipolar electrocoagulation and heater probe treatment of chronic rectal bleeding from radiation telangiectasiaGastrointestinal Endoscopy, 1997
- Patient-controlled analgesia for mucositis pain in children: A three-period crossover study comparing morphine and hydromorphoneThe Journal of Pediatrics, 1996
- Use of patient-controlled analgesia for pain control for children receiving bone marrow transplantJournal of Pain and Symptom Management, 1995
- Mucositis management practices for hospitalized patients: National survey resultsJournal of Pain and Symptom Management, 1995
- Severe hemorrhagic radiation proctitis advancing to gradual cessation with hyperbaric oxygenDigestive Diseases and Sciences, 1991
- Radiation-induced proctosigmoiditisDigestive Diseases and Sciences, 1991
- Local benefit of prostaglandin E2 in radiochemotherapy-induced oral mucositisBritish Journal of Oral and Maxillofacial Surgery, 1990